NASDAQ:AGTC
Delisted

Applied Genetic Technologies Stock Signals

etoro logo Buy AGTC
*Your capital is at risk
$0.397
+0 (+0%)
At Close: Feb 28, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Applied Genetic Technologies Corporation

General

Signal Type Signal Value Data
Score 0.000 63 days ( -5.87 %
Last Price $0.397 0 %
Performance History
7 Days
$0.397 $0.397
0%
30 Days
$0.397 $0.397
0%
12 Mos
$1.99 $0.397
-80.05%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.397 - $0.397
Trend - 3 mos 0.270 % High Width: 2.00 %
Pred. range - 3 mos $0.391 - $0.399 Low -1.53 % - 0.443 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Feb 27, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Dec 13, 2022 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.33
Signal Type Signal Value Importance Data
Trend - 12 mos -54.63 % Very High Width: 332.11 %
Pred. range - 12 mos N/A - $0.398 High -100.00 % - 0.342 %
Short MA 12 mos Buy Very High Nov 28, 2022 - 63 days
Long MA 12 mos Buy Very High Nov 28, 2022 - 63 days
Short/Long MA 12 mos Buy Very High Nov 28, 2022 - 63 days
Pivot Long Sell Low Feb 27, 2023 - 2 days
RSI Long Pivot Signal Sell Low Dec 22, 2022 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT APPLIED GENETIC TECHNOLOGIES CORPORATION
Applied Genetic Technologies
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE